Proteomic Profile at Revision Arthroplasty for Periprosthetic Joint Infection Correlates with Disease Stage and Surgical Outcome
Ontology highlight
ABSTRACT: Periprosthetic joint infection (PJI) is both the most common and difficult to treat form of arthroplasty failure, occurring in ~2% of primary total knee and hip arthroplasties. For patient and surgeon alike, treating PJI with DAIR surgery (debridement, antibiotics, and implant retention) is preferable to implant resection surgery due to medical costs, patient morbidity, and required skill, however, DAIR success rates are variable. Therefore, an accurate diagnostic to identify candidates who will undergo DAIR successfully would be clinically helpful. To achieve this, advanced proteomic analysis of sonicate fluid from 95 subjects with PJI was performed using proximity extension assay (PEA), with 77 samples additionally undergoing liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis. A group of 120 proteins was identified that successfully separates DAIR samples into success or failure categories and predicts DAIR surgery outcome post-hoc. Additionally, the proteomic signature associated with short symptom duration and long symptom duration PJI was defined and used to categorize samples into 2 putative stages of infection. The investigation of 7,261 unique human proteins was employed here to explore the physiology of PJI and reveals a proteomic signature for DAIR failure as well as insight into PJI protein profiles based on patient reported symptom duration.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Bodily Fluid
DISEASE(S): Joint Inflammation
SUBMITTER:
Akhilesh Pandey
LAB HEAD: Akhilesh Pandey
PROVIDER: PXD058084 | Pride | 2025-08-26
REPOSITORIES: Pride
ACCESS DATA